Total Payments
$5,521
2023 Payments
$101.04
Companies
26
Transactions
380
Medicare Patients
2,507
Medicare Billing
$224,422
Payment Breakdown by Category
Food & Beverage$5,418 (98.1%)
Gifts$73.31 (1.3%)
Education$29.16 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,418 | 374 | 98.1% |
| Gift | $73.31 | 1 | 1.3% |
| Education | $29.16 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $1,365 | 73 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,104 | 88 | $0 (2020) |
| Takeda Pharmaceuticals America, Inc. | $437.02 | 35 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $313.23 | 20 | $0 (2020) |
| Shire North American Group Inc | $299.81 | 20 | $0 (2019) |
| Gilead Sciences, Inc. | $270.59 | 21 | $0 (2019) |
| Braintree Laboratories, Inc. | $213.09 | 10 | $0 (2021) |
| Synergy Pharmaceuticals Inc | $204.40 | 19 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $201.86 | 12 | $0 (2017) |
| Romark Laboratories, LC | $179.67 | 13 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $101.04 | 2 | AbbVie Inc. ($101.04) |
| 2021 | $109.51 | 3 | Braintree Laboratories, Inc. ($73.31) |
| 2020 | $365.54 | 20 | Takeda Pharmaceuticals U.S.A., Inc. ($150.91) |
| 2019 | $1,361 | 97 | Takeda Pharmaceuticals U.S.A., Inc. ($366.73) |
| 2018 | $1,858 | 138 | Takeda Pharmaceuticals U.S.A., Inc. ($586.52) |
| 2017 | $1,725 | 120 | AbbVie, Inc. ($452.30) |
All Payment Transactions
380 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/13/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: IMMUNOLOGY | ||||||
| 06/07/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $85.41 | General |
| Category: IMMUNOLOGY | ||||||
| 12/15/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL HEMOSTASIS (Device) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/19/2021 | Braintree Laboratories, Inc. | SUTAB (Drug) | Gift | Cash or cash equivalent | $73.31 | General |
| Category: GI COLON PREP | ||||||
| 04/02/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/12/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/11/2020 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/03/2020 | RedHill Biopharma Inc. | Aemcolo (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Antibiotic | ||||||
| 02/28/2020 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/14/2020 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/13/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/04/2020 | RedHill Biopharma Inc. | Aemcolo (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Antibiotic | ||||||
| 01/31/2020 | Takeda Pharmaceuticals U.S.A., Inc. | AMITIZA (Drug) | Food and Beverage | In-kind items and services | $6.96 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/29/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: IMMUNOLOGY | ||||||
| 01/29/2020 | Romark Laboratories, LC | ALINIA (Drug), ALINIA, ALINIA | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Gastroenterology | ||||||
| 01/28/2020 | Romark Laboratories, LC | ALINIA (Drug), ALINIA, ALINIA | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Gastroenterology | ||||||
| 01/22/2020 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/21/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: IMMUNOLOGY | ||||||
| 01/21/2020 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/15/2020 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/14/2020 | RedHill Biopharma Inc. | Aemcolo (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Antibiotic | ||||||
| 01/13/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/10/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/10/2020 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 574 | 585 | $279,225 | $47,983 |
| 2022 | 12 | 546 | 565 | $284,107 | $50,220 |
| 2021 | 17 | 673 | 756 | $320,258 | $63,374 |
| 2020 | 17 | 714 | 823 | $251,829 | $62,845 |
Total Patients
2,507
Total Services
2,729
Medicare Billing
$224,422
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 66 | 66 | $82,962 | $12,747 | 15.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 41 | 41 | $34,604 | $6,869 | 19.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 37 | 37 | $31,228 | $6,205 | 19.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 57 | 57 | $40,242 | $4,558 | 11.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 37 | 37 | $10,619 | $3,482 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $7,825 | $2,871 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 36 | $5,616 | $2,289 | 40.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $15,244 | $2,211 | 14.5% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 23 | 24 | $5,088 | $1,471 | 28.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 26 | $3,952 | $1,432 | 36.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $12,240 | $1,221 | 10.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 15 | $3,240 | $1,170 | 36.1% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 164 | 165 | $20,295 | $567.65 | 2.8% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 11 | 11 | $1,650 | $480.80 | 29.1% |
| 43450 | Dilation of esophagus | Facility | 2023 | 13 | 13 | $4,420 | $407.25 | 9.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 66 | 66 | $82,962 | $12,206 | 14.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 61 | 61 | $51,484 | $10,588 | 20.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $18,467 | $6,729 | 36.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 31 | 31 | $26,164 | $5,391 | 20.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 49 | 49 | $34,594 | $3,859 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 33 | $7,128 | $3,087 | 43.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 53 | $8,056 | $2,820 | 35.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $18,768 | $1,909 | 10.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $11,208 | $1,416 | 12.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 17 | $2,652 | $1,166 | 44.0% |
About Dr. David Thomas, MD
Dr. David Thomas, MD is a Gastroenterology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104860329.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Thomas, MD has received a total of $5,521 in payments from pharmaceutical and medical device companies, with $101.04 received in 2023. These payments were reported across 380 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($5,418).
As a Medicare-enrolled provider, Thomas has provided services to 2,507 Medicare beneficiaries, totaling 2,729 services with total Medicare billing of $224,422. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Indianapolis, IN
- Active Since 06/16/2006
- Last Updated 03/09/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1104860329
Products in Payments
- Entyvio (Biological) $782.44
- Humira (Biological) $664.76
- Creon (Drug) $419.37
- Amitiza (Drug) $362.29
- XIFAXAN (Drug) $341.79
- GATTEX (Drug) $318.85
- Trulance (Drug) $204.40
- SUPREP (Drug) $139.78
- Dexilant (Drug) $129.20
- Alinia Tablets 500mg 30 count bottle (Drug) $114.23
- STELARA (Biological) $110.51
- RINVOQ (Biological) $101.04
- Cimzia (Drug) $97.62
- Donnatal (Drug) $91.75
- MOTEGRITY (Drug) $83.59
- XIFAXANIBSD (Drug) $83.40
- SUTAB (Drug) $73.31
- Motegrity (Drug) $71.01
- HUMIRA (Biological) $68.20
- LINZESS (Drug) $67.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Indianapolis
Douglas Rex, M.d, M.D
Gastroenterology — Payments: $785,487
Gastroenterology $785,487
Ajay Jain, Md, MD
Gastroenterology — Payments: $435,795
Gastroenterology $435,795
Dr. David Pound, M.d, M.D
Gastroenterology — Payments: $207,527
Gastroenterology $207,527
Raj Vuppalanchi, M.d, M.D
Gastroenterology — Payments: $183,853
Gastroenterology $183,853
Thomas Imperiale, M.d, M.D
Gastroenterology — Payments: $154,570
Gastroenterology $154,570
Glen Lehman, M.d, M.D
Gastroenterology — Payments: $98,291
Gastroenterology $98,291